Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of ...

Delve into the field of miRNA with 7 promising companies with miRNA-focused candidates in the pipeline, from oncology to neurodegeneration.

As the signs point toward a potential Evotec acquisition, delve into what it could represent for the European biotech ...

Find out how Google DeepMind's AlphaFold3 platform could help scientists revolutionize the field of drug discovery.

After years of setbacks, biotechs are advancing treatments for Huntington’s disease, offering new hope as clinical studies ...

The hypoparathyroidism treatment space has made a buzz in 2024 with a major drug approval, acquisitions, and big advances in ...

Labiotech provides listing of 2025 biotech conferences and events purely as a service for readers. We are not responsible for any errors in dates or omissions. Please check event websites for further ...

Do you know who Jonathan Milner is? If you’ve ever worked in a biotech lab, chances are you’ve benefited from his legacy. The founder of Abcam, Jonathan Milner, transformed the way scientists access ...

Bispecific antibodies seem to be all the rage at the minute. Their ability to deliver targeted therapeutics to patients with a two-in-one approach by simultaneously binding to two different antigens ...